(首都医科大学宣武医院药物研究室,北京市老年病医疗研究中心,神经变性病教育部重点实验室,北京市神经药物工程研究中心,北京 100053)
R-33
国家自然科学基金项目(编号:81673406);北京市科技专项(编号:Z131102002813066);北京市高层次卫生技术人才计划(编号:2011?1?7);首都卫生发展科研专项(编号:首发2016?2?1033)
MA Denglei
Department of Pharmacology, Xuanwu Hospital of Capital Medical University; Beijing Geriatric Medical Research Center; Key Laboratory of Neurodegenerative Diseases of Ministry of Education; Beijing Engineering Research Center of Nerve System Drugs, Beijing 100053, ChinaZHANG Ruyi
Department of Pharmacology, Xuanwu Hospital of Capital Medical University; Beijing Geriatric Medical Research Center; Key Laboratory of Neurodegenerative Diseases of Ministry of Education; Beijing Engineering Research Center of Nerve System Drugs, Beijing 100053, China(Department of Pharmacology, Xuanwu Hospital of Capital Medical University; Beijing Geriatric Medical Research Center; Key Laboratory of Neurodegenerative Diseases of Ministry of Education; Beijing Engineering Research Center of Nerve System Drugs, Beijing 100053, China)
马登磊,张如意,李林.P301L突变tau蛋白转基因动物模型及其应用[J].中国比较医学杂志,2018,28(1):123~128.
复制